Alphabetic index · D

Disorder(of)

see also Disease

Sub-terms

acantholyticL11.9
specified NECL11.8
acute
adjustment (grief)F43.20
with
anxietyF43.22
with depressed moodF43.23
conduct disturbanceF43.24
with emotional disturbanceF43.25
depressed moodF43.21
with anxietyF43.23
other specified symptomF43.29
adrenal (capsule) (gland) (medullary)E27.9
specified NECE27.8
drug-inducedE25.8
iatrogenicE25.8
idiopathicE25.8
adult personality (and behavior)F69
specified NECF68.8
affective (mood)see Disorder, mood
aggressive, unsocializedF91.1
alcohol-relatedF10.99
with
amnestic disorder, persistingF10.96
anxiety disorderF10.980
dementia, persistingF10.97
intoxicationF10.929
with deliriumF10.921
uncomplicatedF10.920
mood disorderF10.94
other specifiedF10.988
psychotic disorderF10.959
with
delusionsF10.950
hallucinationsF10.951
sexual dysfunctionF10.981
sleep disorderF10.982
alcohol use
mildF10.10
with
alcohol-induced
anxiety disorderF10.180
bipolar and related disorderF10.14
depressive disorderF10.14
psychotic disorderF10.159
sexual dysfunctionF10.181
sleep disorderF10.182
alcohol intoxicationF10.129
deliriumF10.121
in remission (early) (sustained)F10.11
moderate or severeF10.20
with
alcohol-induced
anxiety disorderF10.280
bipolar and related disorderF10.24
depressive disorderF10.24
major neurocognitive disorder, amnestic-confabulatory typeF10.26
major neurocognitive disorder, nonamnestic-confabulatory typeF10.27
mild neurocognitive disorderF10.288
psychotic disorderF10.259
sexual dysfunctionF10.281
sleep disorderF10.282
alcohol intoxicationF10.229
deliriumF10.221
in remission (early) (sustained)F10.21
allergicsee Allergy
alveolar NECJ84.09
amino-acid
cystathioninuriaE72.19
cystinosisE72.04
cystinuriaE72.01
glycinuriaE72.09
homocystinuriaE72.11
specified NECE72.89
neonatal, transitoryP74.8
renal transport NECE72.09
transport NECE72.09
amnesic, amnestic
alcohol-inducedF10.96
with dependenceF10.26
due to (secondary to) general medical conditionF04
psychoactive NEC-inducedF19.96
with
abuseF19.16
dependenceF19.26
sedative, hypnotic or anxiolytic-inducedF13.96
with dependenceF13.26
amphetamine-type substance use
mildF15.10
in remission (early) (sustained)F15.11
moderateF15.20
in remission (early) (sustained)F15.21
severeF15.20
in remission (early) (sustained)F15.21
amphetamine (or other stimulant) use
mild
with
amphetamine (or other stimulant)-induced
anxiety disorderF15.180
bipolar and related disorderF15.14
depressive disorderF15.14
obsessive-compulsive and related disorderF15.188
psychotic disorderF15.159
sexual dysfunctionF15.181
amphetamine, cocaine, or other stimulant intoxication
with perceptual disturbancesF15.122
without perceptual disturbancesF15.129
intoxication deliriumF15.121
moderate or severe
with
amphetamine (or other stimulant)-induced
anxiety disorderF15.280
obsessive-compulsive and related disorderF15.288
sexual dysfunctionF15.281
bipolar and related disorderF15.24
depressive disorderF15.24
psychotic disorderF15.259
amphetamine, cocaine, or other stimulant intoxication
with perceptual disturbancesF15.222
without perceptual disturbancesF15.229
intoxication deliriumF15.221
anaerobic glycolysis with anemiaD55.29
anxietyF41.9
due to (secondary to)
alcoholF10.980
in
abuseF10.180
dependenceF10.280
amphetamineF15.980
in
abuseF15.180
dependenceF15.280
anxiolyticF13.980
in
abuseF13.180
dependenceF13.280
caffeineF15.980
in
abuseF15.180
dependenceF15.280
cannabisF12.980
in
abuseF12.180
dependenceF12.280
cocaineF14.980
in
abuseF14.180
dependenceF14.180
general medical conditionF06.4
hallucinogenF16.980
in
abuseF16.180
dependenceF16.280
hypnoticF13.980
in
abuseF13.180
dependenceF13.280
inhalantF18.980
in
abuseF18.180
dependenceF18.280
phencyclidineF16.980
in
abuseF16.180
dependenceF16.280
psychoactive substance NECF19.980
in
abuseF19.180
dependenceF19.280
sedativeF13.980
in
abuseF13.180
dependenceF13.280
volatile solventsF18.980
in
abuseF18.180
dependenceF18.280
generalizedF41.1
illnessF45.21
mixed
with depression (mild)F41.8
specified NECF41.3
organicF06.4
phobicF40.9
of childhoodF40.8
specified NECF41.8
aromatic amino-acid metabolismE70.9
specified NECE70.89
arteriole NECI77.89
artery NECI77.89
attachment (childhood)
disinhibitedF94.2
reactiveF94.1
attention-deficit hyperactivity (adolescent) (adult) (child)F90.9
combined
presentationF90.2
typeF90.2
hyperactive
impulsive presentationF90.1
typeF90.1
inattentive
presentationF90.0
typeF90.0
specified type NECF90.8
attention-deficit without hyperactivity (adolescent) (adult) (child)F98.8
auditory processing (central)H93.25
autisticF84.0
autism spectrumF84.0
autoimmuneD89.89
autonomic nervous systemG90.9
specified NECG90.89
avoidant
child or adolescentF40.10
restrictive food intakeF50.82
balance
acid-baseE87.8
mixedE87.4
electrolyteE87.8
fluid NECE87.8
behavioral (disruptive)see Disorder, conduct
bereavement, persistent complexF43.81
beta-amino-acid metabolismE72.89
bile acid and cholesterol metabolismE78.70
Barth syndromeE78.71
other specifiedE78.79
Smith-Lemli-Opitz syndromeE78.72
bilirubin excretionE80.6
binge eatingF50.81-needs more characters
binocular
movementH51.9
convergence
excessH51.12
insufficiencyH51.11
internuclear ophthalmoplegiasee Ophthalmoplegia, internuclear
palsy of conjugate gazeH51.0
specified type NECH51.8
bipolar (I) (seasonal) (type 1)F31.9
and related due to a known physiological condition
with
manic featuresF06.33
manic- or hypomanic-like episodesF06.33
mixed featuresF06.34
current (or most recent) episode
depressedF31.9
with psychotic featuresF31.5
without psychotic featuresF31.30
mildF31.31
moderateF31.32
severe (without psychotic features)F31.4
with psychotic featuresF31.5
hypomanicF31.0
manicF31.9
with psychotic featuresF31.2
without psychotic featuresF31.10
mildF31.11
moderateF31.12
severe (without psychotic features)F31.13
with psychotic featuresF31.2
mixedF31.60
mildF31.61
moderateF31.62
severe (without psychotic features)F31.63
with psychotic featuresF31.64
severe depression (without psychotic features)F31.4
with psychotic featuresF31.5
in remission (currently)F31.70
in full remission
most recent episode
depressedF31.76
hypomanicF31.72
manicF31.74
mixedF31.78
in partial remission
most recent episode
depressedF31.75
hypomanicF31.71
manicF31.73
mixedF31.77
II (type 2)F31.81
organicF06.30
single manic episodeF30.9
mildF30.11
moderateF30.12
severe (without psychotic symptoms)F30.13
with psychotic symptomsF30.2
specified NECF31.89
bladderN32.9
functional NECN31.9
in schistosomiasisB65.0N33
specified NECN32.89
bleedingD68.9
bloodD75.9
in congenital early syphilisA50.09D77
body dysmorphicF45.22
boneM89.9
continuityM84.9
specified type NECM84.80
ankleM84.87-needs more characters
fibulaM84.86-needs more characters
footM84.87-needs more characters
handM84.84-needs more characters
humerusM84.82-needs more characters
neckM84.88
pelvisM84.859
radiusM84.83-needs more characters
shoulderM84.81-needs more characters
skullM84.88
thighM84.85-needs more characters
tibiaM84.86-needs more characters
ulnaM84.83-needs more characters
vertebraM84.88
density and structureM85.9
diffuse idiopathic skeletal hyperostosissee Hyperostosis, ankylosing
fibrous dysplasia (monostotic)see Dysplasia, fibrous, bone
hyperostosis of skullM85.2
osteitis condensanssee Osteitis, condensans
specified type NECM85.8-needs more characters
ankleM85.87-needs more characters
footM85.87-needs more characters
forearmM85.83-needs more characters
handM85.84-needs more characters
lower legM85.86-needs more characters
multiple sitesM85.89
neckM85.88
shoulderM85.81-needs more characters
skullM85.88
thighM85.85-needs more characters
upper armM85.82-needs more characters
vertebraM85.88
development and growth NECM89.20
carpusM89.24-needs more characters
clavicleM89.21-needs more characters
femurM89.25-needs more characters
fibulaM89.26-needs more characters
fingerM89.24-needs more characters
humerusM89.22-needs more characters
iliumM89.28
ischiumM89.28
metacarpusM89.24-needs more characters
metatarsusM89.27-needs more characters
multiple sitesM89.29
neckM89.28
radiusM89.23-needs more characters
scapulaM89.21-needs more characters
skullM89.28
tarsusM89.27-needs more characters
tibiaM89.26-needs more characters
toeM89.27-needs more characters
ulnaM89.23-needs more characters
vertebraM89.28
specified type NECM89.8X-needs more characters
brachial plexusG54.0
branched-chain amino-acid metabolismE71.2
specified NECE71.19
breastN64.9
agalactiasee Agalactia
associated with
lactationO92.70
specified NECO92.79
pregnancyO92.20
specified NECO92.29
puerperiumO92.20
specified NECO92.29
cracked nipplesee Cracked nipple
galactorrheasee Galactorrhea
hypogalactiaO92.4
lactation disorder NECO92.79
mastitissee Mastitis
nipple infectionsee Infection, nipple
retracted nipplesee Retraction, nipple
specified type NECN64.89
Briquet'sF45.0
bullous, in diseases classified elsewhereL14
caffeine use
mild
with
caffeine-induced
anxiety disorderF15.180
sleep disorderF15.182
moderate or severe
with
caffeine-induced
anxiety disorderF15.280
sleep disorderF15.282
cannabis use
mildF12.10
with
cannabis-induced
anxiety disorderF12.180
psychotic disorderF12.159
sleep disorderF12.188
cannabis intoxication deliriumF12.121
with perceptual disturbancesF12.122
without perceptual disturbancesF12.129
in remission (early) (sustained)F12.11
moderate or severeF12.20
with
cannabis-induced
anxiety disorderF12.280
psychotic disorderF12.259
sleep disorderF12.288
cannabis intoxication
with perceptual disturbancesF12.222
without perceptual disturbancesF12.229
deliriumF12.221
in remission (early) (sustained)F12.21
carbohydrate
absorption, intestinal NECE74.39
metabolism (congenital)E74.9
specified NECE74.89
cardiac, functionalI51.89
carnitine metabolismE71.40
cartilageM94.9
chondrocalcinosissee Chondrocalcinosis
specified type NECM94.8X-needs more characters
catatonia (due to known physiological condition) (with another mental disorder)F06.1
catatonic NOSF06.1
due to (secondary to) known physiological conditionF06.1
organic NOSF06.1
central auditory processingH93.25
cervical
region NECM53.82
root (nerve) NECG54.2
character NOSF60.9
childhood disintegrative NECF84.3
cholesterol and bile acid metabolismE78.70
Barth syndromeE78.71
other specifiedE78.79
Smith-Lemli-Opitz syndromeE78.72
choroidH31.9
ciliary bodysee Disorder, iris
citrate metabolism NECE74.829
citrate transporter, SLC13A5E74.820
newborn, transientP61.6
cocaine use
mildF14.10
with
amphetamine, cocaine, or other stimulant intoxication
with perceptual disturbancesF14.122
without perceptual disturbancesF14.129
cocaine-induced
anxiety disorderF14.180
bipolar and related disorderF14.14
depressive disorderF14.14
obsessive-compulsive and related disorderF14.188
psychotic disorderF14.159
sexual dysfunctionF14.181
sleep disorderF14.182
cocaine intoxication deliriumF14.121
in remission (early) (sustained)F14.11
moderate or severeF14.20
with
amphetamine, cocaine, or other stimulant intoxication
with perceptual disturbancesF14.222
without perceptual disturbancesF14.229
cocaine-induced
anxiety disorderF14.280
bipolar and related disorderF14.24
depressive disorderF14.24
obsessive-compulsive and related disorderF14.288
psychotic disorderF14.259
sexual dysfunctionF14.281
sleep disorderF14.282
cocaine intoxication deliriumF14.221
in remission (early) (sustained)F14.21
coccyx NECM53.3
cognitiveF09
due to (secondary to) general medical conditionF09
persistingR41.89
due to
alcoholF10.97
with dependenceF10.27
anxiolyticsF13.97
with dependenceF13.27
hypnoticsF13.97
with dependenceF13.27
sedativesF13.97
with dependenceF13.27
specified substance NECF19.97
with
abuseF19.17
dependenceF19.27
communicationF80.9
social pragmaticF80.82
conduct (childhood)F91.9
adjustment reactionsee Disorder, adjustment
adolescent onset typeF91.2
childhood onset typeF91.1
compulsiveF63.9
confined to family contextF91.0
depressiveF91.8
group typeF91.2
oppositional defianceF91.3
socializedF91.2
solitary aggressive typeF91.1
specified NECF91.8
unsocialized (aggressive)F91.1
conduction, heartI45.9
congenital glycosylation (CDG)E74.89
conjunctivaH11.9
connective tissue, localizedL94.9
specified NECL94.8
conversion (functional neurological symptom disorder)
with
abnormal movementF44.4
anesthesia or sensory lossF44.6
attacks or seizuresF44.5
mixed symptomsF44.7
special sensory symptomsF44.6
speech symptomsF44.4
swallowing symptomsF44.4
weakness or paralysisF44.4
convulsive (secondary)see Convulsions
corneaH18.9
due to contact lensH18.82-needs more characters
specified as edemasee Edema, cornea
keratitissee Keratitis
keratoconjunctivitissee Keratoconjunctivitis
specified type NECH18.89-needs more characters
corpus cavernosumN48.9
Cyclin-Dependent Kinase-Like 5 Deficiency (CDKL5)G40.42
cyclothymicF34.0
defiant oppositionalF91.3
delusional (persistent) (systematized)F22
inducedF24
depersonalizationF48.1
depressiveF32.A
due to known physiological condition
with
depressive featuresF06.31
major depressive-like episodeF06.32
mixed featuresF06.34
majorF32.9
with psychotic symptomsF32.3
in remission (full)F32.5
partialF32.4
recurrentF33.9
with psychotic featuresF33.3
single episodeF32.9
mildF32.0
moderateF32.1
severe (without psychotic symptoms)F32.2
with psychotic symptomsF32.3
organicF06.31
persistentF34.1
recurrentF33.9
current episode
mildF33.0
moderateF33.1
severe (without psychotic symptoms)F33.2
with psychotic symptomsF33.3
in remissionF33.40
fullF33.42
partialF33.41
specified NECF33.8
specified NECF32.89
developmentalF89
arithmetical skillsF81.2
coordination (motor)F82
expressive writingF81.81
languageF80.9
expressiveF80.1
mixed receptive and expressiveF80.2
receptive typeF80.2
specified NECF80.89
learningF81.9
arithmeticalF81.2
readingF81.0
mixedF88
motor coordination or functionF82
pervasiveF84.9
specified NECF84.8
phonologicalF80.0
readingF81.0
mixedF81.89
specified NECF88
speechF80.9
articulationF80.0
specified NECF80.89
written expressionF81.81
diaphragmJ98.6
digestive (system)K92.9
newbornP78.9
specified NECP78.89
psychogenicF45.8
disc (intervertebral)M51.9
with
myelopathy
cervical regionM50.00
cervicothoracic regionM50.03
high cervical regionM50.01
lumbar regionM51.06
mid-cervical regionM50.020
sacrococcygeal regionM53.3
thoracic regionM51.04
thoracolumbar regionM51.05
radiculopathy
cervical regionM50.10
cervicothoracic regionM50.13
high cervical regionM50.11
lumbar regionM51.16
lumbosacral regionM51.17
mid-cervical regionM50.120
sacrococcygeal regionM53.3
thoracic regionM51.14
thoracolumbar regionM51.15
cervicalM50.90
with
myelopathyM50.00
C2-C3M50.01
C3-C4M50.01
C4-C5M50.021
C5-C6M50.022
C6-C7M50.023
C7-T1M50.03
cervicothoracic regionM50.03
high cervical regionM50.01
mid-cervical regionM50.020
neuritis, radiculitis or radiculopathyM50.10
C2-C3M50.11
C3-C4M50.11
C4-C5M50.121
C5-C6M50.122
C6-C7M50.123
C7-T1M50.13
cervicothoracic regionM50.13
high cervical regionM50.11
mid-cervical regionM50.120
C2-C3M50.91
C3-C4M50.91
C4-C5M50.921
C5-C6M50.922
C6-C7M50.923
C7-T1M50.93
cervicothoracic regionM50.93
degenerationM50.30
C2-C3M50.31
C3-C4M50.31
C4-C5M50.321
C5-C6M50.322
C6-C7M50.323
C7-T1M50.33
cervicothoracic regionM50.33
high cervical regionM50.31
mid-cervical regionM50.320
displacementM50.20
C2-C3M50.21
C3-C4M50.21
C4-C5M50.221
C5-C6M50.222
C6-C7M50.223
C7-T1M50.23
cervicothoracic regionM50.23
high cervical regionM50.21
mid-cervical regionM50.220
high cervical regionM50.91
mid-cervical regionM50.920
specified type NECM50.80
C2-C3M50.81
C3-C4M50.81
C4-C5M50.821
C5-C6M50.822
C6-C7M50.823
C7-T1M50.83
cervicothoracic regionM50.83
high cervical regionM50.81
mid-cervical regionM50.820
specified NEC
lumbar regionM51.86
lumbosacral regionM51.87
sacrococcygeal regionM53.3
thoracic regionM51.84
thoracolumbar regionM51.85
disinhibited attachment (childhood)F94.2
disintegrative, childhood NECF84.3
disruptiveF91.9
mood dysregulationF34.81
specified NECF91.8
disruptive behaviorsee Disorder, conduct
dissocial personalityF60.2
dissociativeF44.9
affecting
motor functionF44.4
and sensationF44.7
sensationF44.6
and motor functionF44.7
brief reactiveF43.0
due to (secondary to) general medical conditionF06.8
mixedF44.7
organicF06.8
other specified NECF44.89
double heterozygous sicklingsee Disease, sickle-cell
dream anxietyF51.5
drug induced hemorrhagicD68.32
drug relatedF19.99
dysmorphic bodyF45.22
dysthymicF34.1
earH93.9-needs more characters
deafnesssee Deafness
degenerativeH93.09-needs more characters
dischargesee Otorrhea
externalH61.9-needs more characters
auditory canal stenosissee Stenosis, external ear canal
impacted cerumensee Impaction, cerumen
specified type NECH61.89-needs more characters
in diseases classified elsewhereH62.8X-needs more characters
innerH83.9-needs more characters
vestibular dysfunctionsee Disorder, vestibular function
middleH74.9-needs more characters
adhesiveH74.1-needs more characters
specified NEC, in diseases classified elsewhereH75.8-needs more characters
specified NEC, in diseases classified elsewhereH94.8-needs more characters
eating (adult) (psychogenic)F50.9
anorexiasee Anorexia
bingeF50.81-needs more characters
bulimiaF50.2-needs more characters
childF98.29
pica (in remission)F98.3
rumination disorder (in remission)F98.21
picaF50.89
adult (in remission)F50.83
childhood (in remission)F98.3
adult (in remission)F50.84
infancy or childhood (in remission)F98.21
specified NECF50.89
electrolyte (balance) NECE87.8
with
acidosis (lactic) (metabolic)E87.20
acuteE87.21
chronicE87.22
respiratoryE87.29
specified NECE87.29
alkalosis (metabolic) (respiratory)E87.3
elimination, transepidermalL87.9
specified NECL87.8
emotional (persistent)F34.9
of childhoodF93.9
specified NECF93.8
endocrineE34.9
postproceduralE89.89
specified NECE89.89
nonorganicF52.21
erythematoussee Erythema
esophagusK22.9
functionalK22.4
psychogenicF45.8
eustachian tubeH69.9-needs more characters
specified NECH69.8-needs more characters
exhibitionisticF65.2
extrapyramidalG25.9
in diseases classified elsewherecoding instruction
specified type NECG25.89
eyelidH02.9
degenerativeH02.70
madarosissee Madarosis
specified type NECH02.79
xanthelasmasee Xanthelasma
dermatochalasissee Dermatochalasis
functionH02.59
abnormal innervation syndromesee Syndrome, abnormal innervation
blepharochalasissee Blepharochalasis
blepharoclonussee Blepharoclonus
blepharophimosissee Blepharophimosis
blepharoptosissee Blepharoptosis
lagophthalmossee Lagophthalmos
lid retractionsee Retraction, lid
specified type NECH02.89
vascularH02.879
lowerH02.875
upperH02.874
rightH02.873
lowerH02.872
upperH02.871
factitious
by proxyF68.A
imposed on anotherF68.A
imposed on selfF68.10
with predominantly
psychological symptomsF68.11
with physical symptomsF68.13
physical symptomsF68.12
with psychological symptomsF68.13
factor, coagulationsee Defect, coagulation
fatty acid
metabolismE71.30
specified NECE71.39
oxidation
specified deficiency NECE71.318
feeding (infant or child)see also Disorder, eatingR63.30
pediatric
acuteR63.31
chronicR63.32
or eating disorderF50.9
specified NECF50.9
feigned (with obvious motivation)Z76.5
without obvious motivationsee Disorder, factitious
female
hypoactive sexual desireF52.0
orgasmicF52.31
sexual interest/arousalF52.22
fetishisticF65.0
fibroblasticM72.9
specified NECM72.8
fluency
adult onsetF98.5
childhood onsetF80.81
following
cerebral infarctionI69.323
cerebrovascular diseaseI69.923
specified disease NECI69.823
intracerebral hemorrhageI69.123
nontraumatic intracranial hemorrhage NECI69.223
subarachnoid hemorrhageI69.023
in conditions classified elsewhereR47.82
fluid balanceE87.8
follicular (skin)L73.9
specified NECL73.8
FOXG1-relatedQA0.0151
frotteuristicF65.81
fructose metabolismE74.10
essential fructosuriaE74.11
fructokinase deficiencyE74.11
fructose-1, 6-diphosphatase deficiencyE74.19
hereditary fructose intoleranceE74.12
other specifiedE74.19
functional polymorphonuclear neutrophilsD71.9
specified NECD71.8
gallbladder, biliary tract and pancreas in diseases classified elsewhereK87
gamblingF63.0
gamma aminobutyric acid (GABA) metabolismE72.81
gamma-glutamyl cycleE72.89
gastric (functional)K31.9
motilityK30
psychogenicF45.8
secretionK30
gastrointestinal (functional) NOSK92.9
newbornP78.9
psychogenicF45.8
gender incongruenceF64.9
in adolescents and adultsF64.0
of childhoodF64.2
gender-identity or -roleF64.9
childhoodF64.2
effect on relationshipF66
of adolescence or adulthoodF64.0
nontranssexualF64.8
specified NECF64.8
uncertaintyF66
genito-pelvic pain penetrationF52.6
genitourinary system
femaleN94.9
maleN50.9
psychogenicF45.8
globeH44.9
degenerated conditionH44.50
absolute glaucomaH44.51-needs more characters
atrophyH44.52-needs more characters
leucocoriaH44.53-needs more characters
degenerativeH44.30
chalcosisH44.31-needs more characters
myopiasee also Myopia, degenerativeH44.2-needs more characters
siderosisH44.32-needs more characters
specified type NECH44.39-needs more characters
endophthalmitissee Endophthalmitis
hemophthalmossee Hemophthalmos
hypotonyH44.40
due to
ocular fistulaH44.42-needs more characters
specified disorder NECH44.43-needs more characters
flat anterior chamberH44.41-needs more characters
primaryH44.44-needs more characters
specified type NECH44.89
glomerular (in)N05.9
amyloidosisE85.4N08
cryoglobulinemiaD89.1N08
disseminated intravascular coagulationD65N08
Fabry's diseaseE75.21N08
familial lecithin cholesterol acyltransferase deficiencyE78.6N08
Goodpasture's syndromeM31.0
hemolytic-uremic syndromesee Syndrome, hemolytic-uremic
Henoch (-Schönlein) purpuraD69.0N08
malariae malariaB52.0
microscopic polyangiitisM31.7N08
multiple myelomaC90.0-needs more charactersN08
mumpsB26.83
schistosomiasisB65.9N08
sepsis NECA41.-needs more charactersN08
streptococcalA40.-needs more charactersN08
sickle-cell disordersD57.-needs more charactersN08
strongyloidiasisB78.9N08
subacute bacterial endocarditisI33.0N08
syphilisA52.75
systemic lupus erythematosusM32.14
thrombotic thrombocytopenic purpuraM31.19N08
Waldenström macroglobulinemiaC88.0-needs more charactersN08
Wegener's granulomatosisM31.31
gluconeogenesisE74.4
glucose transportE74.819
specified NECE74.818
glycine metabolismE72.50
d-glycericacidemiaE72.59
hyperhydroxyprolinemiaE72.59
hyperoxaluriaR82.992
dietaryE72.540
entericE72.541
primaryE72.539
specified type NECE72.538
type 1E72.530
type 2E72.538
type 3E72.538
secondaryE72.549
specified type NECE72.548
hyperprolinemiaE72.59
non-ketotic hyperglycinemiaE72.51
oxalosisE72.53
oxaluriaE72.53
sarcosinemiaE72.59
trimethylaminuriaE72.52
glycoprotein metabolismE77.9
specified NECE77.8
grief
complicatedF43.81
prolongedF43.81
habit (and impulse)F63.9
involving sexual behavior NECF65.9
specified NECF63.89
hallucinogen use
mildF16.10
with
hallucinogen-induced
anxiety disorderF16.180
bipolar and related disorderF16.14
depressive disorderF16.14
psychotic disorderF16.159
hallucinogen intoxication deliriumF16.121
other hallucinogen intoxicationF16.129
in remission (early) (sustained)F16.11
moderate or severeF16.20
with
hallucinogen-induced
anxiety disorderF16.280
bipolar and related disorderF16.24
depressive disorderF16.24
psychotic disorderF16.259
hallucinogen intoxication deliriumF16.221
other hallucinogen intoxicationF16.229
in remission (early) (sustained)F16.21
heart actionI49.9
hematologicalD75.9
newborn (transient)P61.9
specified NECP61.8
hematopoietic organsD75.9
hemorrhagic NECD69.9
drug-inducedD68.32
due to
extrinsic circulating anticoagulantsD68.32
increase in
anti-IIaD68.32
anti-XaD68.32
intrinsic
circulating anticoagulantsD68.318
increase in
antithrombinD68.318
anti-VIIIaD68.318
anti-IXaD68.318
anti-XIaD68.318
following childbirthO72.3
histidine metabolismE70.40
histidinemiaE70.41
other specifiedE70.49
hoardingF42.3
hyperleucine-isoleucinemiaE71.19
hypervalinemiaE71.19
hypoactive sexual desireF52.0
hypochondriacalF45.20
body dysmorphicF45.22
neurosisF45.21
other specifiedF45.29
identity
dissociativeF44.81
of childhoodF93.8
illness anxietyF45.21
immune mechanism (immunity)D89.9
specified type NECD89.89
impaired renal tubular functionN25.9
specified NECN25.89
impulse (control)F63.9
inflammatory
pelvic, in diseases classified elsewherecoding instruction
penisN48.29
abscessN48.21
cellulitisN48.22
inhalant use
mildF18.10
with
inhalant-induced
anxiety disorderF18.180
depressive disorderF18.14
major neurocognitive disorderF18.17
mild neurocognitive disorderF18.188
psychotic disorderF18.159
inhalant intoxicationF18.129
inhalant intoxication deliriumF18.121
in remission (early) (sustained)F18.11
moderate or severeF18.20
with
inhalant-induced
anxiety disorderF18.280
depressive disorderF18.24
major neurocognitive disorderF18.27
mild neurocognitive disorderF18.288
psychotic disorderF18.259
inhalant intoxicationF18.229
inhalant intoxication deliriumF18.221
in remission (early) (sustained)F18.21
integument, newbornP83.9
specified NECP83.88
intermittent explosiveF63.81
intestine, intestinal
carbohydrate absorption NECE74.39
postoperativeK91.2
functional NECK59.9
postoperativeK91.89
psychogenicF45.8
vascularK55.9
chronicK55.1
specified NECK55.8
intraoperative (intraprocedural)see Complications, intraoperative
involuntary emotional expression (IEED)F48.2
irisH21.9
chamber angle recessionsee Recession, chamber angle
in diseases classified elsewhereH22
iridodialysissee Iridodialysis
iridoschisissee Iridoschisis
miotic pupillary cystsee Cyst, pupillary
pupillary
specified type NECH21.89
vascular NECH21.1X-needs more characters
iron metabolismE83.10
specified NECE83.19
isovaleric acidemiaE71.110
jaw, developmentalM27.0
temporomandibularsee also Anomaly, dentofacial, temporomandibular jointM26.60-needs more characters
jointM25.9
hemarthrosissee Hemarthrosis
osteophytesee Osteophyte
psychogenicF45.8
specified type NECM25.80
ankleM25.87-needs more characters
elbowM25.82-needs more characters
foot jointM25.87-needs more characters
hand jointM25.84-needs more characters
hipM25.85-needs more characters
kneeM25.86-needs more characters
shoulderM25.81-needs more characters
wristM25.83-needs more characters
ketone metabolismE71.32
kidneyN28.9
functional (tubular)N25.9
in
schistosomiasisB65.9N29
tubular functionN25.9
specified NECN25.89
lacrimal systemH04.9
lactation NECO92.79
language (developmental)F80.9
expressiveF80.1
mixed receptive and expressiveF80.2
receptiveF80.2
late luteal phase dysphoricN94.89
learning (specific)F81.9
acalculiaR48.8
alexiaR48.0
mathematicsF81.2
readingF81.0
specified
with impairment in
mathematicsF81.2
readingF81.0
written expressionF81.81
specified NECF81.89
spellingF81.81
written expressionF81.81
lensH27.9
cataractsee Cataract
specified type NECH27.8
ligamentM24.20
ankleM24.27-needs more characters
attachment, spinesee Enthesopathy, spinal
elbowM24.22-needs more characters
foot jointM24.27-needs more characters
hand jointM24.24-needs more characters
hipM24.25-needs more characters
shoulderM24.21-needs more characters
specified site NECM24.29
vertebraM24.28
wristM24.23-needs more characters
ligamentous attachmentssee also Enthesopathy
lipid
metabolism, congenitalE78.9
storageE75.6
specified NECE75.5
lipoprotein
deficiency (familial)E78.6
metabolismE78.9
specified NECE78.89
liverK76.9
malarialB54K77
lumbosacral
plexusG54.1
root (nerve) NECG54.4
lung, interstitial, drug-inducedJ70.4
acuteJ70.2
chronicJ70.3
dabbing (related)U07.0
e-cigarette (related)U07.0
electronic cigarette (related)U07.0
vaping (associated) (device) (product) (related) (use)U07.0
lymphoproliferative, post-transplant (PTLD)D47.Z1
lysine and hydroxylysine metabolismE72.3
major neurocognitivesee also Dementia, in (due to)F03-needs more characters
male
nonorganicF52.21
hypoactive sexual desireF52.0
orgasmicF52.32
manicF30.9
organicF06.33
mast cell activationsee Activation, mast cell
meninges, specified type NECG96.198
menopausalN95.9
specified NECN95.8
menstrualN92.6
psychogenicF45.8
specified NECN92.5
mental (or behavioral) (nonpsychotic)F99
due to (secondary to)
amphetamine
due to drug dependencesee Dependence, drug, stimulant
brain disease, damage and dysfunctionF09
caffeine use
due to drug dependencesee Dependence, drug, stimulant
cannabis use
due to drug abusesee Abuse, drug, cannabis
due to drug dependencesee Dependence, drug, cannabis
general medical conditionF09
sedative or hypnotic use
due to drug abusesee Abuse, drug, sedative
due to drug dependencesee Dependence, drug, sedative
tobacco (nicotine) usesee Dependence, drug, nicotine
following organic brain damageF07.9
frontal lobe syndromeF07.0
personality changeF07.0
postconcussional syndromeF07.81
specified NECF07.89
infancy, childhood or adolescenceF98.9
neuroticsee Neurosis
organic or symptomaticF09
presenile, psychoticF03
problem NECcoding instruction
psychoneuroticsee Neurosis
psychoticsee Psychosis
puerperalF53.0
senile, psychotic NECF03
metabolic, amino acid, transitory, newbornP74.8
metabolism NOSE88.9
amino-acidE72.9
aromaticE70.9
albinismsee Albinism
histidineE70.40
histidinemiaE70.41
other specifiedE70.49
hyperphenylalaninemiaE70.1
classical phenylketonuriaE70.0
other specifiedE70.89
tryptophanE70.5
tyrosineE70.20
hypertyrosinemiaE70.21
other specifiedE70.29
branched chainE71.2
3-methylglutaconic aciduriaE71.111
hyperleucine-isoleucinemiaE71.19
hypervalinemiaE71.19
isovaleric acidemiaE71.110
maple syrup urine diseaseE71.0
methylmalonic acidemiaE71.120
organic aciduria NECE71.118
other specifiedE71.19
propionate NECE71.128
propionic acidemiaE71.121
glycineE72.50
d-glycericacidemiaE72.59
hyperhydroxyprolinemiaE72.59
hyperoxaluriaR82.992
primaryE72.53
hyperprolinemiaE72.59
non-ketotic hyperglycinemiaE72.51
other specifiedE72.59
sarcosinemiaE72.59
trimethylaminuriaE72.52
hydroxylysineE72.3
lysineE72.3
ornithineE72.4
other specifiedE72.89
beta-amino acidE72.89
gamma-glutamyl cycleE72.89
straight-chainE72.89
sulfur-bearingE72.10
homocystinuriaE72.11
methylenetetrahydrofolate reductase deficiencyE72.12
other specifiedE72.19
bile acid and cholesterol metabolismE78.70
bilirubinE80.7
specified NECE80.6
calciumE83.50
hypercalcemiaE83.52
hypocalcemiaE83.51
other specifiedE83.59
carbohydrateE74.9
specified NECE74.89
cholesterol and bile acid metabolismE78.70
citrate NECE74.829
congenitalE88.9
copperE83.00
Wilson's diseaseE83.01
specified type NECE83.09
cystinuriaE72.01
fructoseE74.10
galactoseE74.20
glucosaminoglycanE76.9
mucopolysaccharidosissee Mucopolysaccharidosis
specified NECE76.8
glutamineE72.89
glycineE72.50
glycogen storage (hepatorenal)E74.09
glycoproteinE77.9
specified NECE77.8
glycosaminoglycanE76.9
specified NECE76.8
in labor and deliveryO75.89
ironE83.10
isoleucineE71.19
leucineE71.19
lipoidE78.9
lipoproteinE78.9
specified NECE78.89
magnesiumE83.40
hypermagnesemiaE83.41
hypomagnesemiaE83.42
other specifiedE83.49
mineralE83.9
specified NECE83.89
mitochondrialE88.40
aminoacyl-tRNA synthetaseE88.43
ARS2-relatedE88.43
MELAS syndromeE88.41
MERRF syndrome (myoclonic epilepsy associated with ragged-red fibers)E88.42
other specifiedE88.49
tRNA synthetasesE88.43
ornithineE72.4
phosphatasesE83.30
phosphorusE83.30
acid phosphatase deficiencyE83.39
hypophosphatasiaE83.39
hypophosphatemiaE83.39
familialE83.31
other specifiedE83.39
pseudovitamin D deficiencyE83.32
plasma protein NECE88.09
porphyrinsee Porphyria
postproceduralE89.89
specified NECE89.89
purineE79.9
specified NECE79.89
pyrimidineE79.9
specified NECE79.89
pyruvateE74.4
serineE72.89
sodiumE87.8
specified NECE88.89
threonineE72.89
valineE71.19
zincE83.2
methylmalonic acidemiaE71.120
feeling of incomplete emptyingR39.14
hesitancyR39.11
poor streamR39.12
psychogenicF45.8
split streamR39.13
strainingR39.16
urgencyR39.15
mild neurocognitiveG31.84
due to known physiological condition (without behavioral disturbance)F06.70
with behavioral disturbanceF06.71
mitochondrial metabolismE88.40
mixed
anxiety and depressiveF41.8
of scholastic skills (developmental)F81.89
receptive expressive languageF80.2
moodF39
due to (secondary to)
alcoholF10.94
amphetamineF15.94
in
abuseF15.14
dependenceF15.24
anxiolyticF13.94
in
abuseF13.14
dependenceF13.24
cocaineF14.94
in
abuseF14.14
dependenceF14.24
general medical conditionF06.30
hallucinogenF16.94
in
abuseF16.14
dependenceF16.24
hypnoticF13.94
in
abuseF13.14
dependenceF13.24
inhalantF18.94
in
abuseF18.14
dependenceF18.24
opioidF11.94
in
abuseF11.14
dependenceF11.24
phencyclidine (PCP)F16.94
in
abuseF16.14
dependenceF16.24
physiological conditionF06.30
with
depressive featuresF06.31
major depressive-like episodeF06.32
manic featuresF06.33
mixed featuresF06.34
psychoactive substance NECF19.94
in
abuseF19.14
dependenceF19.24
sedativeF13.94
in
abuseF13.14
dependenceF13.24
volatile solventsF18.94
in
abuseF18.14
dependenceF18.24
manic episodeF30.9
with psychotic symptomsF30.2
in remission (full)F30.4
partialF30.3
specified type NECF30.8
without psychotic symptomsF30.10
mildF30.11
moderateF30.12
severeF30.13
organicF06.30
right hemisphereF07.89
persistentF34.9
cyclothymiaF34.0
dysthymiaF34.1
specified type NECF34.89
recurrentF39
right hemisphere organicF07.89
movementG25.9
drug-inducedG25.70
akathisiaG25.71
specified NECG25.79
hystericalF44.4
in diseases classified elsewherecoding instruction
periodic limbG47.61
sleep relatedG47.61
specified NECG25.89
sleep related NECG47.69
stereotypedF98.4
treatment-inducedG25.9
multiple personalityF44.81
muscleM62.9
attachment, spinesee Enthesopathy, spinal
psychogenicF45.8
specified type NECM62.89
tone, newbornP94.9
specified NECP94.8
muscular
musculoskeletal system, soft tissuesee Disorder, soft tissue
postproceduralM96.89
psychogenicF45.8
myoneuralG70.9
due to leadG70.1
specified NECG70.89
toxicG70.1
myotonic NECG71.19
nail, in diseases classified elsewhereL62
neonatal onset multisystemic inflammatory (NOMID)M04.2
nerveG58.9
accessoryG52.8
acousticcoding instruction
auditorycoding instruction
auriculotemporalG50.8
axillaryG54.0
cranialG52.9
eighthcoding instruction
eleventhG52.8
fifthG50.9
firstG52.0
multipleG52.7
ninthG52.1
seventh NECG51.8
specified NECG52.8
tenthG52.2
twelfthG52.3
facialG51.9
specified NECG51.8
glossopharyngeal NECG52.1
hypoglossalG52.3
intercostalG58.0
lateral
multipleG58.7
olfactoryG52.0
optic NECH47.09-needs more characters
hemorrhage into sheathsee Hemorrhage, optic nerve
ischemicH47.01-needs more characters
phrenicG58.8
pneumogastricG52.2
recurrent laryngealG52.2
rootG54.9
cervicalG54.2
lumbosacralG54.1
specified NECG54.8
thoracicG54.3
specified NECG58.8
sympatheticG90.9
trigeminalG50.9
specified NECG50.8
vagusG52.2
nervous systemG98.8
autonomic (peripheral)G90.9
specified NECG90.89
centralG96.9
specified NECG96.89
parasympatheticG90.9
specified NECG98.8
sympatheticG90.9
vegetativeG90.9
neurocognitiveR41.9
majorsee also DementiaF03.-needs more characters
due to vascular diseasesee Dementia, vascular
in (due to) (other diseases classified elsewhere)see also Dementia, in (due to)F02.80
with
aggressive behaviorsee also Dementia, in (due to)F02.81-needs more characters
combative behaviorsee also Dementia, in (due to)F02.81-needs more characters
violent behaviorsee also Dementia, in (due to)F02.81-needs more characters
mild (of uncertain or unknown etiology)see also Disorder, mild neurocognitiveG31.84
neurodevelopmentalF89
CACNA1A-relatedQA0.0102
DLG4-related synaptopathyQA0.0142
FOXG1-relatedQA0.0151
GRIN1-relatedQA0.011
GRIN2A-relatedQA0.011
GRIN2B-relatedQA0.011
GRIN2D-relatedQA0.011
GRIA1-relatedQA0.011
GRIA2-relatedQA0.011
GRIA3-relatedQA0.011
GRIA4-relatedQA0.011
GRIK2-relatedQA0.011
other
glutamate receptor, ionotropic, relatedQA0.011
ion channel gene relatedQA0.0109
receptor gene relatedQA0.012
related to other genes associated with transcription and gene expressionQA0.0159
synapse related geneQA0.0149
transporter or solute carrier gene relatedQA0.0139
SCN2A-relatedQA0.0101
SLC6A1-relatedQA0.0131
STXBP1-relatedQA0.0141
syntaxin-binding protein 1-relatedQA0.0141
specified NECF88
related to pathogenic variants in specific genes NECQA0.8
neurohypophysis NECE23.3
neurological NECR29.818
TUBB4A-relatedG23.3
neuromuscularG70.9
hereditary NECG71.9
specified NECG70.89
toxicG70.1
neuroticF48.9
specified NECF48.8
neutrophil, polymorphonuclearD71.9
specified NECD71.8
nightmareF51.5
non-rapid eye movement sleep arousal
sleep terror typeF51.4
sleepwalking typeF51.3
noseJ34.9
specified NECJ34.89
obsessive-compulsiveF42.9
and related disorder due to a known physiological conditionF06.8
odontogenesis NOSK00.9
opioid use
with
opioid-induced psychotic disorderF11.959
with
delusionsF11.950
hallucinationsF11.951
due to drug abusesee Abuse, drug, opioid
due to drug dependencesee Dependence, drug, opioid
mildF11.10
with
opioid-induced
anxiety disorderF11.188
depressive disorderF11.14
sexual dysfunctionF11.181
opioid intoxication
with perceptual disturbancesF11.122
deliriumF11.121
without perceptual disturbancesF11.129
in remission (early) (sustained)F11.11
moderate or severeF11.20
with
opioid-induced
anxiety disorderF11.288
anxiety disorderF11.988
depressive disorderF11.24
depressive disorderF11.94
sexual dysfunctionF11.281
sexual dysfunctionF11.981
opioid intoxication
with perceptual disturbancesF11.222
deliriumF11.221
without perceptual disturbancesF11.229
in remission (early) (sustained)F11.21
oppositional defiantF91.3
optic
chiasmH47.49
due to
inflammatory disorderH47.41
neoplasmH47.42
vascular disorderH47.43
discH47.39-needs more characters
orbitH05.9
organic
anxietyF06.4
catatonic NOSF06.1
delusionalF06.2
dissociativeF06.8
emotionally labile (asthenic)F06.8
mood (affective)F06.30
schizophrenia-likeF06.2
orgasmic (female)F52.31
maleF52.32
ornithine metabolismE72.4
overanxiousF41.1
of childhoodF93.8
pain
with related psychological factorsF45.42
exclusively related to psychological factorsF45.41
genito-pelvic penetration disorderF52.6
pancreatic internal secretionE16.9
specified NECE16.8
panicF41.0
with agoraphobiaF40.01
papulosquamousL44.9
in diseases classified elsewhereL45
specified NECL44.8
paranoidF22
inducedF24
sharedF24
paraphilicF65.9
specified NECF65.89
parathyroid (gland)E21.5
specified NECE21.4
parietoalveolar NECJ84.09
paroxysmal, mixedR56.9
patellaM22.9-needs more characters
derangement NECM22.3X-needs more characters
recurrent
specified NECM22.8X-needs more characters
patellofemoralM22.2X-needs more characters
pedophilicF65.4
pentose phosphate pathway with anemiaD55.1
perception, due to hallucinogensF16.983
in
abuseF16.183
dependenceF16.283
peripheral nervous system NECG64
peroxisomalE71.50
biogenesis
neonatal adrenoleukodystrophyE71.511
specified disorder NECE71.518
Zellweger syndromeE71.510
rhizomelic chondrodysplasia punctataE71.540
specified form NECE71.548
group 1E71.518
group 2E71.53
group 3E71.542
X-linked adrenoleukodystrophyE71.529
adolescentE71.521
adrenomyeloneuropathyE71.522
childhoodE71.520
specified form NECE71.528
Zellweger-like syndromeE71.541
persistent
(somatoform) painF45.41
affective (mood)F34.9
affectiveF34.0
aggressiveF60.3
amoralF60.2
anankasticF60.5
antisocialF60.2
anxiousF60.6
asocialF60.2
asthenicF60.7
avoidantF60.6
borderlineF60.3
change (secondary) due to general medical conditionF07.0
compulsiveF60.5
cyclothymicF34.0
dependent (passive)F60.7
depressiveF34.1
dissocialF60.2
emotional instabilityF60.3
expansive paranoidF60.0
explosiveF60.3
following organic brain damageF07.9
histrionicF60.4
hyperthymicF34.0
hypothymicF34.1
hystericalF60.4
immatureF60.89
inadequateF60.7
labileF60.3
mixed (nonspecific)F60.89
moral deficiencyF60.2
narcissisticF60.81
negativisticF60.89
obsessionalF60.5
obsessive (-compulsive)F60.5
organicF07.9
overconscientiousF60.5
paranoidF60.0
passive (-dependent)F60.7
passive-aggressiveF60.89
pathological NECF60.9
pseudosocialF60.2
psychopathicF60.2
schizoidF60.1
schizotypalF21
self-defeatingF60.7
specified NECF60.89
type AF60.5
unstable (emotional)F60.3
pervasive, developmentalF84.9
phencyclidine use
mildF16.10
with
phencyclidine-induced
anxiety disorderF16.180
bipolar and related disorderF16.14
depressive disorderF16.14
psychotic disorderF16.159
phencyclidine intoxicationF16.129
phencyclidine intoxication deliriumF16.121
in remission (early) (sustained)F16.11
moderate or severeF16.20
with
phencyclidine-induced
anxiety disorderF16.280
bipolar and related disorderF16.24
depressive disorderF16.24
psychotic disorderF16.259
phencyclidine intoxicationF16.229
phencyclidine intoxication deliriumF16.221
in remission (early) (sustained)F16.21
phobic anxiety, childhoodF40.8
phosphate-losing tubularN25.0
pigmentationL81.9
choroid, congenitalQ14.3
diminished melanin formationL81.6
ironL81.8
specified NECL81.8
pinna (noninfective)H61.10-needs more characters
deformity, acquiredH61.11-needs more characters
hematomaH61.12-needs more characters
specified type NECH61.19-needs more characters
pituitary glandE23.7
iatrogenic (postprocedural)E89.3
specified NECE23.6
platelet-activating anti-PF4, specified NECD75.84
plateletsD69.1
plexusG54.9
specified NECG54.8
polymorphonuclear neutrophilsD71.9
specified NECD71.8
porphyrin metabolismsee Porphyria
postconcussionalF07.81
posthallucinogen perceptionF16.983
in
abuseF16.183
dependenceF16.283
postmenopausalN95.9
specified NECN95.8
postprocedural (postoperative)see Complications, postprocedural
post-transplant lymphoproliferativeD47.Z1
post-traumatic stress (PTSD)F43.10
acuteF43.11
chronicF43.12
premenstrual dysphoric (PMDD)F32.81
prepuceN47.8
propionic acidemiaE71.121
prostateN42.9
specified NECN42.89
anxietyF41.8
appetiteF50.9
asthenicF48.8
cardiovascular (system)F45.8
compulsiveF42.8
cutaneousF54
depressiveF32.9
digestive (system)F45.8
dysmenorrheicF45.8
dyspneicF45.8
endocrine (system)F54
eye NECF45.8
functional NECF45.8
gastricF45.8
gastrointestinal (system)F45.8
genitourinary (system)F45.8
heart (function) (rhythm)F45.8
hyperventilatoryF45.8
intestinalF45.8
jointF45.8
learningF81.9
limbF45.8
lymphatic (system)F45.8
menstrualF45.8
micturitionF45.8
monoplegic NECF44.4
motorF44.4
muscleF45.8
musculoskeletalF45.8
neurocirculatoryF45.8
obsessiveF42.8
occupationalF48.8
organ or part of body NECF45.8
paralytic NECF44.4
phobicF40.9
physical NECF45.8
rectalF45.8
respiratory (system)F45.8
rheumaticF45.8
sexual (function)F52.9
skin (allergic) (eczematous)F54
sleepF51.9
specified part of body NECF45.8
stomachF45.8
psychologicalF99
associated with
disease classified elsewhereF54
sexual
developmentF66
relationshipF66
uncertainty about gender identityF64.9
psychomotor NECF44.4
hystericalF44.4
psychoneuroticsee also Neurosis
mixed NECF48.8
psychophysiologicsee Disorder, somatoform
psychosexualF65.9
developmentF66
identity of childhoodF64.2
psychosomatic NOSsee Disorder, somatoform
multipleF45.0
undifferentiatedF45.1
psychoticsee Psychosis
transient (acute)F23
pubertyE30.9
specified NECE30.8
purine metabolismE79.9
pyrimidine metabolismE79.9
pyruvate metabolismE74.4
reactive attachment (childhood)F94.1
readingR48.0
developmental (specific)F81.0
receptive languageF80.2
recurrent brief depressiveF33.8
reflexR29.2
refractionH52.7
aniseikoniaH52.32
anisometropiaH52.31
astigmatismsee Astigmatism
hypermetropiasee Hypermetropia
presbyopiaH52.4
specified NECH52.6
relationshipF68.8
due to sexual orientationF66
REM sleep behaviorG47.52
renal function, impaired (tubular)N25.9
resonanceR49.9
specified NECR49.8
respiratory function, impairedsee also Failure, respiration
retinaH35.9
angioid streaksH35.33
changes in vascular appearanceH35.01-needs more characters
dystrophy (hereditary)see Dystrophy, retina
edemaH35.81
ischemiaH35.82
macular degenerationsee Degeneration, macula
microaneurysmsH35.04-needs more characters
microvascular abnormality NECH35.09
retinopathysee Retinopathy
separation of layersH35.70
central serous chorioretinopathyH35.71-needs more characters
pigment epithelium detachment (serous)H35.72-needs more characters
hemorrhagicH35.73-needs more characters
specified type NECH35.89
retroperitonealK68.9
right hemisphere organic affectiveF07.89
rumination (infant or child) (in remission)F98.21
adult (in remission)F50.84
sacrum, sacrococcygeal NECM53.3
schizoaffectiveF25.9
bipolar typeF25.0
depressive typeF25.1
manic typeF25.0
mixed typeF25.0
specified NECF25.8
schizoid of childhoodF84.5
schizophrenia spectrum and other psychotic disorderF29
specified NECF28
schizophreniformF20.81
briefF23
schizotypal (personality)F21
seasonal affective, recurrent episodesF33.-needs more characters
secretion, thyrocalcitoninE07.0
sedative, hypnotic, or anxiolytic use
mildF13.10
with
sedative, hypnotic, or anxiolytic-induced
anxiety disorderF13.180
bipolar and related disorderF13.14
depressive disorderF13.14
psychotic disorderF13.159
sexual dysfunctionF13.181
sedative, hypnotic, or anxiolytic intoxicationF13.129
sedative, hypnotic, or anxiolytic intoxication deliriumF13.121
in remission (early) (sustained)F13.11
moderate or severeF13.20
with
sedative, hypnotic, or anxiolytic-induced
anxiety disorderF13.280
bipolar and related disorderF13.24
depressive disorderF13.24
major neurocognitive disorderF13.27
mild neurocognitive disorderF13.288
psychotic disorderF13.259
sexual dysfunctionF13.281
sedative, hypnotic, or anxiolytic intoxicationF13.229
sedative, hypnotic, or anxiolytic intoxication deliriumF13.221
in remission (early) (sustained)F13.21
intractableG40.919
with status epilepticusG40.911
semantic pragmaticF80.89
with autismF84.0
sense of smellR43.1
psychogenicF45.8
separation anxiety, of childhoodF93.0
sexual
arousal, femaleF52.22
aversionF52.1
function, psychogenicF52.9
interest/arousal, femaleF52.22
masochismF65.51
maturationF66
nonorganicF52.9
fetishistic transvestismF65.1
relationshipF66
sadismF65.52
shyness, of childhood and adolescenceF40.10
sibling rivalryF93.8
sickle-cell (sickling) (homozygous)see Disease, sickle-cell
heterozygousD57.3
specified type NECD57.8-needs more characters
traitD57.3
sinus (nasal)J34.9
specified NECJ34.89
skinL98.9
atrophicL90.9
specified NECL90.8
granulomatousL92.9
specified NECL92.8
hypertrophicL91.9
specified NECL91.8
infiltrative NECL98.6
newbornP83.9
specified NECP83.88
pickingF42.4
psychogenic (allergic) (eczematous)F54
SLC13A5 Citrate Transporter DisorderE74.820
sleepG47.9
breathing-relatedsee Apnea, sleep
circadian rhythmG47.20
advance sleep phase typeG47.22
delayed sleep phase typeG47.21
due to
alcohol
abuseF10.182
dependenceF10.282
amphetamines
abuseF15.182
dependenceF15.282
caffeine
abuseF15.182
dependenceF15.282
cocaine
abuseF14.182
dependenceF14.282
drug NEC
abuseF19.182
dependenceF19.282
opioid
abuseF11.182
dependenceF11.282
psychoactive substance NEC
abuseF19.182
dependenceF19.282
sedative, hypnotic, or anxiolytic
abuseF13.182
dependenceF13.282
stimulant NEC
abuseF15.182
dependenceF15.282
free running typeG47.24
in conditions classified elsewhereG47.27
irregular sleep wake typeG47.23
jet lag typeG47.25
non-24-hour sleep-wake typeG47.24
shift work typeG47.26
specified NECG47.29
due to
alcohol
abuseF10.182
dependenceF10.282
amphetamine
abuseF15.182
dependenceF15.282
anxiolytic
abuseF13.182
dependenceF13.282
caffeine
abuseF15.182
dependenceF15.282
cocaine
abuseF14.182
dependenceF14.282
drug NEC
abuseF19.182
dependenceF19.282
hypnotic
abuseF13.182
dependenceF13.282
opioid
abuseF11.182
dependenceF11.282
psychoactive substance NEC
abuseF19.182
dependenceF19.282
sedative
abuseF13.182
dependenceF13.282
stimulant NEC
abuseF15.182
dependenceF15.282
emotionalF51.9
excessive somnolencesee Hypersomnia
hypersomnia typesee Hypersomnia
initiating or maintainingsee Insomnia
nightmaresF51.5
nonorganicF51.9
specified NECF51.8
parasomnia typeG47.50
specified NECG47.8
terrorsF51.4
walkingF51.3
specified NECG47.8
social
anxiety (of childhood)F40.10
generalizedF40.11
functioning in childhoodF94.9
specified NECF94.8
pragmaticF80.82
soft tissueM79.9
ankleM79.9
due to use, overuse and pressureM70.90
ankleM70.97-needs more characters
bursitissee Bursitis
footM70.97-needs more characters
forearmM70.93-needs more characters
handM70.94-needs more characters
lower legM70.96-needs more characters
multiple sitesM70.99
pelvic regionM70.95-needs more characters
shoulder regionM70.91-needs more characters
specified site NECM70.98
specified type NECM70.80
ankleM70.87-needs more characters
footM70.87-needs more characters
forearmM70.83-needs more characters
handM70.84-needs more characters
lower legM70.86-needs more characters
multiple sitesM70.89
pelvic regionM70.85-needs more characters
shoulder regionM70.81-needs more characters
specified site NECM70.88
thighM70.85-needs more characters
upper armM70.82-needs more characters
thighM70.95-needs more characters
upper armM70.92-needs more characters
footM79.9
forearmM79.9
handM79.9
lower legM79.9
multiple sitesM79.9
pelvic regionM79.9
shoulder regionM79.9
specified type NECM79.89
thighM79.9
upper armM79.9
somatic symptomF45.1
somatizationF45.0
somatoformF45.9
pain (persistent)F45.41
somatization (multiple) (long-lasting)F45.0
specified NECF45.8
undifferentiatedF45.1
somnolence, excessivesee Hypersomnia
specific
arithmeticalF81.2
developmental, of motorF82
readingF81.0
speech and languageF80.9
spellingF81.81
written expressionF81.81
speechR47.9
articulation (functional) (specific)F80.0
developmentalF80.9
specified NECR47.89
speech-soundF80.0
spelling (specific)F81.81
ligamentous or muscular attachments, peripheralsee Enthesopathy, spinal
stereotyped, habit or movementF98.4
stimulant use (other) (unspecified)
mildF15.10
in remission (early) (sustained)F15.11
moderate or severeF15.20
in remission (early) (sustained)F15.21
stomach (functional)see Disorder, gastric
stressF43.9
acuteF43.0
post-traumaticF43.10
acuteF43.11
chronicF43.12
substance use (other) (unknown)
mildF19.10
with substance-induced
anxiety disorderF19.180
bipolar and related disorderF19.14
depressive disorderF19.14
major neurocognitive disorderF19.17
mild neurocognitive disorderF19.188
obsessive-compulsive and related disorderF19.188
sexual dysfunctionF19.181
substance intoxicationF19.129
substance intoxication deliriumF19.121
moderate or severeF19.20
with substance-induced
anxiety disorderF19.280
bipolar and related disorderF19.24
depressive disorderF19.24
major neurocognitive disorderF19.27
mild neurocognitive disorderF19.288
obsessive-compulsive and related disorderF19.288
sexual dysfunctionF19.281
in remission (early) (sustained)F19.21
substance intoxicationF19.229
substance intoxication deliriumF19.221
sulfur-bearing amino-acid metabolismE72.10
sweat gland (eccrine)L74.9
apocrineL75.9
specified NECL75.8
specified NECL74.8
synoviumM67.90
acromioclavicularM67.91-needs more characters
ankleM67.97-needs more characters
elbowM67.92-needs more characters
footM67.97-needs more characters
forearmM67.93-needs more characters
handM67.94-needs more characters
hipM67.95-needs more characters
kneeM67.96-needs more characters
multiple sitesM67.99
shoulderM67.91-needs more characters
specified type NECM67.80
acromioclavicularM67.81-needs more characters
ankleM67.87-needs more characters
elbowM67.82-needs more characters
footM67.87-needs more characters
handM67.84-needs more characters
hipM67.85-needs more characters
kneeM67.86-needs more characters
multiple sitesM67.89
wristM67.83-needs more characters
synovitissee Synovitis
upper armM67.92-needs more characters
wristM67.93-needs more characters
temperature regulation, newbornP81.9
specified NECP81.8
temporomandibular jointM26.60-needs more characters
tendonM67.90
acromioclavicularM67.91-needs more characters
ankleM67.97-needs more characters
elbowM67.92-needs more characters
footM67.97-needs more characters
forearmM67.93-needs more characters
handM67.94-needs more characters
hipM67.95-needs more characters
kneeM67.96-needs more characters
multiple sitesM67.99
shoulderM67.91-needs more characters
specified type NECM67.80
acromioclavicularM67.81-needs more characters
ankleM67.87-needs more characters
elbowM67.82-needs more characters
footM67.87-needs more characters
handM67.84-needs more characters
hipM67.85-needs more characters
kneeM67.86-needs more characters
multiple sitesM67.89
trunkM67.88
wristM67.83-needs more characters
synovitissee Synovitis
tendinitissee Tendinitis
tenosynovitissee Tenosynovitis
trunkM67.98
upper armM67.92-needs more characters
wristM67.93-needs more characters
thoracic root (nerve) NECG54.3
thyrocalcitonin hypersecretionE07.0
thyroid (gland)E07.9
function NEC, neonatal, transitoryP72.2
iodine-deficiency relatedE01.8
specified NECE07.89
tobacco use
chewing tobacco (mild) (moderate) (severe)
in remission (early) (sustained)F17.221
cigarettes (mild) (moderate) (severe)
in remission (early) (sustained)F17.211
in remission (early) (sustained)F17.201
moderateF17.200
in remission (early) (sustained)F17.201
severeF17.200
in remission (early) (sustained)F17.201
specified product NEC (mild) (moderate) (severe)
in remission (early) (sustained)F17.291
toothK08.9
developmentK00.9
specified NECK00.8
eruptionK00.6
Tourette'sF95.2
trance and possessionF44.89
transvesticF65.1
trauma and stressor-related NOSF43.9
other specifiedF43.89
unspecifiedF43.9
tryptophan metabolismE70.5
tubular, phosphate-losingN25.0
tubulo-interstitial (in)
brucellosisA23.9N16
cystinosisE72.04
diphtheriaA36.84
glycogen storage diseaseE74.00N16
leukemia NECC95.9-needs more charactersN16
lymphoma NECC85.9-needs more charactersN16
mixed cryoglobulinemiaD89.1N16
multiple myelomaC90.0-needs more charactersN16
Salmonella infectionA02.25
sarcoidosisD86.84
sepsisA41.9N16
streptococcalA40.9N16
systemic lupus erythematosusM32.15
toxoplasmosisB58.83
transplant rejectionT86.91N16
Wilson's diseaseE83.01N16
tubulo-renal function, impairedN25.9
specified NECN25.89
tympanic membraneH73.9-needs more characters
specified NECH73.89-needs more characters
unsocialized aggressiveF91.1
urea cycle metabolismE72.20
argininemiaE72.21
arginosuccinic aciduriaE72.22
citrullinemiaE72.23
ornithine transcarbamylase deficiencyE72.4
other specifiedE72.29
ureter (in)N28.9
schistosomiasisB65.0N29
tuberculosisA18.11
urethraN36.9
specified NECN36.8
urinary systemN39.9
specified NECN39.8
valve, heart
vestibular functionH81.9-needs more characters
specified NEC
in diseases classified elsewhereH82.-needs more characters
vision, binocularH53.30
abnormal retinal correspondenceH53.31
diplopiaH53.2
fusion with defective stereopsisH53.32
simultaneous perceptionH53.33
suppressionH53.34
visual
cortex
blindnessH47.619
left brainH47.612
right brainH47.611
due to
inflammatory disorderH47.629
left brainH47.622
right brainH47.621
neoplasmH47.639
left brainH47.632
right brainH47.631
vascular disorderH47.649
left brainH47.642
right brainH47.641
pathwayH47.9
due to
inflammatory disorderH47.51-needs more characters
neoplasmH47.52-needs more characters
vascular disorderH47.53-needs more characters
vitreous bodyH43.9
voiceR49.9
specified type NECR49.8
volatile solvent use
due to drug abusesee Abuse, drug, inhalant
due to drug dependencesee Dependence, drug, inhalant
voyeuristicF65.3
white blood cellsD72.9
specified NECD72.89
withdrawing, child or adolescentF40.10

Index entries point you to a code — always verify it in the tabular list before assigning.